ArticleBMC cancer2026
Sex- and age- specific lung cancer incidence and mortality among Medicaid beneficiaries with and without HIV, 2001-2015.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPeople with HIV (PWH) have higher lung cancer incidence and poorer prognosis than people without HIV (PWoH). PWoH experience age and sex-based differences in lung cancer. However, evidence on sex- and age-specific trends among PWH are limited.
methodsWe evaluated lung cancer incidence for Medicaid beneficiaries aged 30-64 from 14 states (2001-2015) by HIV status. We used Cox models and inverse probability weighting to estimate the hazard ratio (HR) of lung cancer and the Aalen-Johansen estimator to calculate the cumulative incidence of lung cancer by HIV status. We estimated the excess mortality ratio (EMR) by comparing the ratio of mortality rate differences before and after lung cancer diagnosis by HIV status.
resultsThere were 1,110 lung cancers over 529,150 person-years among PWH and 8,256 lung cancers over 8,110,847 person-years among PWoH. HIV was associated with the hazard of lung cancer incidence (HR: 1.75, 95% CI:1.56, 1.96); the strongest association was among female beneficiaries aged 30-49 (HR: 3.71, 95% CI: 2.59, 5.32). Lung cancer incidence rates declined over time for all beneficiaries; however, the smallest decrease was in female PWH. PWH experienced significant excess mortality after lung cancer diagnosis compared to PWoH (EMR:1.24, 95% CI:1.06, 1.43); this was strongest among female beneficiaries aged 30-49 (EMR: 2.18, 95% CI: 1.46, 3.12).
conclusionsPWH had elevated incidence of lung cancer and excess mortality after lung cancer compared to PWoH. Importantly, these findings were strongest among young female beneficiaries with HIV, highlighting the need for lung cancer prevention and early detection among this group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.